MarketCap
Facebook
X
TelegramAnnual report 2025
added 03-09-2026
Myomo EV - Enterprise Value 2011-2026 | MYO
Annual EV - Enterprise Value Myomo
| 2025 | 2024 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 47 M | 23.7 M | 4.1 M | 32.5 M | 32.7 M | 5.13 M | 16.2 M | 7.65 M | 19.2 M | 65.3 K | - | - | - | - |
All numbers in USD currency
Indicator range from annual reports
| Maximum | Minimum | Average |
|---|---|---|
| 47 M | 65.3 K | 18.8 M |
EV - Enterprise Value of other stocks in the Medical devices industry
| Issuer | EV - Enterprise Value | Price | % 24h | Market Cap | Country | |
|---|---|---|---|---|---|---|
 |
BIOLASE
BIOL
|
26.8 M | - | -13.19 % | $ 166 K |  USA |
 |
GenMark Diagnostics, Inc.
GNMK
|
76.6 M | - | - | $ 1.77 B | USA |
 |
Allied Healthcare Products
AHPI
|
696 K | - | 3.58 % | $ 2.21 M | USA |
 |
Lianluo Smart Limited
LLIT
|
655 M | - | 24.59 % | $ 44.8 M |  China |
 |
Eargo
EAR
|
-53 M | - | - | $ 10.2 M | USA |
 |
Apollo Endosurgery
APEN
|
423 M | - | - | $ 475 M | USA |
 |
Obalon Therapeutics, Inc.
OBLN
|
-5.83 M | - | -5.86 % | $ 30.6 M | USA |
 |
Helius Medical Technologies
HSDT
|
3.7 M | $ 2.13 | -1.39 % | $ 1.29 M | USA |
 |
Delcath Systems
DCTH
|
295 M | $ 11.44 | 3.81 % | $ 410 M | USA |
 |
Second Sight Medical Products
EYES
|
7.43 M | - | -0.97 % | $ 54.4 M | USA |
 |
Electromed
ELMD
|
170 M | $ 25.21 | -1.6 % | $ 213 M | USA |
 |
Avinger
AVGR
|
17.3 M | - | -20.74 % | $ 369 K | USA |
 |
Axonics Modulation Technologies
AXNX
|
2.67 B | - | - | $ 3.31 B | USA |
 |
EDAP TMS S.A.
EDAP
|
139 M | $ 3.49 | 4.49 % | $ 131 M |  France |
 |
Aziyo Biologics
AZYO
|
-1.67 M | - | 1.37 % | $ 20.5 M | USA |
 |
BioSig Technologies
BSGM
|
33.9 M | - | 37.08 % | $ 85.7 M | USA |
 |
Conformis
CFMS
|
3.84 M | - | - | $ 16.4 M | USA |
 |
Inspire Medical Systems
INSP
|
1.78 B | $ 46.15 | -15.91 % | $ 1.36 B | USA |
 |
ClearPoint Neuro
CLPT
|
340 M | $ 11.25 | 0.63 % | $ 319 M | USA |
 |
LivaNova PLC
LIVN
|
4.58 B | $ 57.82 | -2.12 % | $ 3.15 B |  Britain |
 |
Cardiovascular Systems
CSII
|
595 M | - | 0.15 % | $ 844 M | USA |
 |
Cytosorbents Corporation
CTSO
|
66.9 M | $ 0.63 | 0.87 % | $ 39.2 M | USA |
 |
CryoLife, Inc.
CRY
|
70.4 M | - | -4.14 % | $ 702 M | USA |
 |
CHF Solutions, Inc.
CHFS
|
-7.7 M | - | 1.15 % | $ 34.5 M | USA |
 |
Invacare Corporation
IVC
|
-34.7 M | - | - | $ 24.7 M | USA |
 |
Soliton, Inc.
SOLY
|
-100 M | - | -1.42 % | $ 435 M | USA |
 |
Hancock Jaffe Laboratories, Inc.
HJLI
|
7.54 B | - | -1.98 % | $ 98.3 M | USA |
 |
IRIDEX Corporation
IRIX
|
34.8 M | $ 1.07 | -1.38 % | $ 18.1 M | USA |
 |
Itamar Medical Ltd.
ITMR
|
427 M | - | 0.03 % | $ 1.58 B |  Israel |
 |
Dynatronics Corporation
DYNT
|
13.8 M | - | 14.99 % | $ 929 K | USA |
 |
Misonix, Inc.
MSON
|
-1.79 M | - | - | $ 462 M | USA |
 |
Neovasc
NVCN
|
639 M | - | - | $ 111 M |  Canada |
 |
Insulet Corporation
PODD
|
19.1 B | $ 169.07 | -1.35 % | $ 11.9 B | USA |
 |
OrthoPediatrics Corp.
KIDS
|
579 M | $ 16.05 | 1.71 % | $ 377 M | USA |
 |
Sintx Technologies
SINT
|
9.34 M | $ 2.38 | 0.42 % | $ 6.6 M | USA |
 |
Butterfly Network
BFLY
|
765 M | $ 4.96 | 2.37 % | $ 1.05 B | USA |
 |
Intersect ENT, Inc.
XENT
|
1.02 B | - | - | $ 955 M | USA |
 |
GBS
GBS
|
6.89 M | - | -0.57 % | $ 7.12 M | USA |
 |
Globus Medical
GMED
|
12.7 B | $ 91.09 | 0.54 % | $ 12.3 B | USA |
 |
NanoVibronix
NAOV
|
3.4 M | - | - | $ 1.08 M | USA |
 |
CONMED Corporation
CNMD
|
2.57 B | $ 36.07 | 0.45 % | $ 1.12 B | USA |
 |
Integer Holdings Corporation
ITGR
|
4.62 B | $ 86.83 | 3.36 % | $ 3.02 B | USA |
 |
TransMedics Group
TMDX
|
4.8 B | $ 96.34 | -0.76 % | $ 3.27 B | USA |
 |
Stryker Corporation
SYK
|
21.4 B | $ 295.54 | 1.54 % | $ 113 B | USA |
 |
Tandem Diabetes Care
TNDM
|
1.9 B | $ 19.25 | -3.12 % | $ 1.31 B | USA |
 |
Edwards Lifesciences Corporation
EW
|
49.3 B | $ 82.79 | -0.65 % | $ 48.4 B | USA |
 |
LENSAR
LNSR
|
142 M | $ 5.51 | -0.9 % | $ 65.9 M | USA |
 |
Pulmonx Corporation
LUNG
|
78.3 M | $ 1.26 | -5.26 % | $ 51.3 M | USA |
 |
MiMedx Group
MDXG
|
699 M | $ 3.71 | 2.77 % | $ 548 M | USA |